Skip to main content
SpringerLink
Log in

Interventionelles Vorgehen ist sicher und effektiv

Rekonstruktion oder Ersatz der Mitralklappe bei Herzinsuffizienz

  • Original- und Übersichtsarbeiten
  • Pro & Kontra
  • Published:
CardioVasc Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Strauss RH, Stevenson LW, Dadourian BA, Child JS. Predictability of mitral regurgitation detected by Doppler echocardiography in patients referred for cardiac transplantation. Am J Cardiol 1987 April 1;59(8):892–4.

    Article  PubMed  CAS  Google Scholar 

  2. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002 September;144(3):524–9.

    Article  PubMed  Google Scholar 

  3. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001 April 3;103(13):1759–64.

    Article  PubMed  CAS  Google Scholar 

  4. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007 January;28(2):230–68.

    Article  PubMed  Google Scholar 

  5. Bach DS, Awais M, Gurm HS, Kohnstamm S. Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol 2009 August 25;54(9):860–5.

    Article  PubMed  Google Scholar 

  6. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007 June;28(11):1358–65.

    Article  PubMed  Google Scholar 

  7. Chiam PT, Ruiz CE. Percutaneous transcatheter mitral valve repair: a classification of the technology. JACC Cardiovasc Interv 2011 January;4(1):1–13.

    Article  PubMed  Google Scholar 

  8. Maisano F, Redaelli A, Pennati G, Fumero R, Torracca L, Alfieri O. The hemodynamic effects of double-sacrifice valve repair for mitral regurgitation: a 3D computational model. Eur J Cardiothorac Surg 1999 April;15(4):419–25.

    Article  PubMed  CAS  Google Scholar 

  9. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009 August 18;54(8):686–94.

    Article  PubMed  Google Scholar 

  10. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011 April 14;364(15):1395–406.

    Article  PubMed  CAS  Google Scholar 

  11. Auricchio A, Schillinger W, Meyer S, Maisano F, Hoffmann R, Ussia GP, Pedrazzini GB, van der HJ, Fratini S, Klersy C, Komtebedde J, Franzen O. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011 November 15;58(21):2183–9.

  12. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, Treede H, Barmeyer A, Schofer J, Costard-Jackle A, Schluter M, Reichenspurner H, Meinertz T. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010 June;31(11):1373–81.

    Article  PubMed  Google Scholar 

  13. Franzen O, van der HJ, Baldus S, Schluter M, Schillinger W, Butter C, Hoffmann R, Corti R, Pedrazzini G, Swaans MJ, Neuss M, Rudolph V, Surder D, Grunenfelder J, Eulenburg C, Reichenspurner H, Meinertz T, Auricchio A. MitraClip(R) therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011 May;13(5):569–76.

    Article  PubMed  Google Scholar 

  14. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, Bajwa T, Herrmann HC, Lasala J, Maddux JT, Tuzcu M, Kapadia S, Trento A, Siegel RJ, Foster E, Glower D, Mauri L, Kar S. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012 January 10;59(2):130–9.

    Article  PubMed  Google Scholar 

  15. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011 April 14;364(15):1395–406.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Deutschland

    C. Hammersting

Authors
  1. C. Hammersting
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Hammersting.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hammersting, C. Interventionelles Vorgehen ist sicher und effektiv. CV 12, 55–58 (2012). https://doi.org/10.1007/s15027-012-0217-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-012-0217-x

Search

Navigation